Tag: Philips

CAMBRIDGE, Mass. – Royal Philips has again been included on the list of America’s Best Employers for Diversity by Forbes. The inclusion of Philips is a testament to the company’s commitment to fostering a diverse and inclusive culture where employees feel valued, safe and supported to be their best, it said in a press release. “We aim to be the best place to work for all our employees, embracing diversity and inclusion and health and well-being,” said Lauren Gohde, Philips...

AMSTERDAM, the Netherlands – Philips reported group sales of EUR 3.9 billion for the first quarter of 2022, with a 4% decline on the back of 9% growth in the same quarter last year.  The company says comparable order intake increased 5%, driven by the Diagnosis & Treatment and Hospital Patient Monitoring businesses.  “Our customers confirm the relevance of our strategy and portfolio, as evidenced by the further growth of our all-time-high order book,” said Frans...

WASHINGTON – CMS on Feb. 10 published a change request notifying the DME Medicare Administrative Contractors of the agency’s new national coverage determination for home oxygen therapy.  CMS notes the following changes are effective for claims with dates of service starting Sept. 27, 2021:  expansion of oxygen coverage for acute and chronic conditions;  expansion of coverage for short and long-term need (when hypoxemia exhibited);  the ability of the...

CAMBRIDGE, Mass. – Royal Philips has received a score of 100% on the Human Rights Campaign Foundation’s 2022 Corporate Equality Index, a national benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. It’s the fourth consecutive year that Philips has been named to the list. "We aim to be the best place to work for our employees, embracing diversity and inclusion, and assuring a safe and healthy work environment," said Lauren...

WASHINGTON – AAHomecare is calling on providers to contact their members of Congress to sign on as original co-sponsors for draft legislation from by Rep. Markwayne Mullins, R.-Okla., and Paul Tonko, D-N.Y., that would provide reimbursement relief.  The legislation would apply 90/10 blended reimbursement rates for the 13 product categories that were removed from Round 2021 of Medicare’s competitive bidding program. The rates would apply from Jan. 1, 2022, through Dec. 31, 2023.  “A...

WASHINGTON – The U.S. Food and Drug Administration obtained additional information during an inspection of a Philips’ manufacturing facility that was not previously available to the agency that showed the silicone-based foam used in a singular, similar device marketed outside the U.S. failed one safety test for the release of volatile organic compounds.  Similar testing provided by Philips to the FDA on devices authorized for marketing in the U.S. had demonstrated acceptable results.  “The...

AMSTERDAM – Philips has issued a recall for its V60 and V60 Plus ventilators equipped with high-flow therapy software versions 3.00 and 3.10 due to the risk of patients receiving reduced oxygen. The number of such devices recalled in the U.S.: 16,535. V60 and V60 Plus ventilators equipped with high-flow therapy are used to provide patients with breathing assistance at high concentrations of oxygen at a higher flow than typical oxygen therapy. These devices include a design safety mechanism...

AMSTERDAM – Philips reported a 16% decline in sales for its Connected Care business, which includes Sleep and Respiratory Care, for the second quarter of 2021 compared to the same period last year, in the wake of a massive recall of certain CPAP devices and ventilators.  Mid-single-digit growth in Hospital Patient Monitoring was more than offset by a double-digit decline in Sleep & Respiratory Care, the company says.  “We have mobilized the necessary resources across the...

AMSTERDAM – The U.S. Food and Drug Administration has classified the voluntary recall of certain Philips CPAP devices and ventilators as Class I.   The FDA defines Class I as “a situation in which there is reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”  The agency posted recalls for the various affected devices, along with their classification, to its database on July 13 and July...

AMSTERDAM – Royal Philips has announced, in consultation with regulatory agencies, a voluntary recall notification on certain Bi-Level CPAP, CPAP and mechanical ventilator devices to address identified potential health risks related to the polyester-based polyurethane sound abatement foam component in these devices.  The majority of affected devices within the advised five-year service life are in the first-generation DreamStation product family, the company says.  “We...